{"protocolSection":{"identificationModule":{"nctId":"NCT04339699","nctIdAliases":["NCT05025475"],"orgStudyIdInfo":{"id":"748824-0819"},"organization":{"fullName":"Nobles Medical Technologies II Inc","class":"INDUSTRY"},"briefTitle":"NobleStitch EL STITCH Trial is a PFO Comparative Trial","officialTitle":"STITCH - Prospective Multi Center Comparative Parallel Concurrent Study of the NobleStitch EL Compared to FDA Approved Amplatzer Occluder Device for Closure of Patent Foramen Ovale to Prevent Recurrent Ischemic Stroke","acronym":"STITCH"},"statusModule":{"statusVerifiedDate":"2023-10","overallStatus":"SUSPENDED","whyStopped":"Sponsor has voluntarily suspended Trial, to update Protocol and respond to observations by the FDA","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-01-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2026-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2027-06-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-04-01","studyFirstSubmitQcDate":"2020-04-06","studyFirstPostDateStruct":{"date":"2020-04-09","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-10-30","lastUpdatePostDateStruct":{"date":"2023-11-01","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Nobles Medical Technologies II Inc","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true},"descriptionModule":{"briefSummary":"STITCH - Prospective Multi-Center Comparative Parallel Concurrent Study of the NobleStitch™ EL versus FDA-approved Amplatzer Occluder device for closure of Patent Foramen Ovale to prevent recurrent Ischemic stroke.","detailedDescription":"To demonstrate the non-inferiority of the NobleStitch™ EL with medical management in both safety and effectiveness compared to the FDA-approved Amplatzer Occluder with medical management for PFO Closure.\n\nTo demonstrate that the NobleStitch EL does not increase the incidence of ischemic stroke compared to published medical management data."},"conditionsModule":{"conditions":["Foramen Ovale, Patent","Stroke, Ischemic"],"keywords":["Patent Foramen Ovale","Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"A 640 participants indicated for percutaneous transcatheter closure of a PFO to reduce risk of recurrent Ischemic Stroke; between ages 18 - 60 years, who have had a Cryptogenic Stroke due to Paradoxical Embolism. To be conducted both in the USA and the European Union.","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":640,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"NobleStitch™EL","type":"ACTIVE_COMPARATOR","description":"Participants treated with the NobleStitch™EL device","interventionNames":["Device: NobleStitch™EL Suture Mediated Closure System"]},{"label":"Amplatzer PFO Occluder","type":"ACTIVE_COMPARATOR","description":"Participants treated with the Amplatzer PFO Occluder device","interventionNames":["Device: Amplatzer PFO Occluder"]}],"interventions":[{"type":"DEVICE","name":"NobleStitch™EL Suture Mediated Closure System","description":"Percutaneous closure of Patent Foramen Ovale (PFO) using NobleStitch™EL suture Medicate Closure System","armGroupLabels":["NobleStitch™EL"]},{"type":"DEVICE","name":"Amplatzer PFO Occluder","description":"Percutaneous closure of Patent Foramen Ovale (PFO) using Amplatzer PFO Occluder","armGroupLabels":["Amplatzer PFO Occluder"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Effective PFO closure rate of the NobleStitch EL","description":"Effectiveness PFO closure rate of NobleStitch EL suture mediated closure with medical management compared to Amplatzer PFO occluder with medical management for PFO closure. Effective PFO closure rate defined as Grade 0 or 1 shunt at rest and during Valsalva at 6 month post closure attempts","timeFrame":"6 months"}],"secondaryOutcomes":[{"measure":"Decreased event rate of recurrent ischemic stroke following PFO closure using NobleStitch EL","description":"Safety of NobleStitch EL suture mediated closure system as compared to Amplatzer PFO Occluder Procedural and device related adverse event rate at 6 month follow up recurrent ischemic stroke through 5 years follow up","timeFrame":"5 years"}],"otherOutcomes":[{"measure":"The occurrence of recurrent ischemic stroke post procedural of patent foramen ovale closure","description":"Examination of Recurrent Ischemic Stroke through 5 year follow up. Comparison of the rate of Stroke associated with the NobleStitch EL procedure to that expected with medical management","timeFrame":"5 Years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Provision of signed and dated informed consent form\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n* Male or female ages 18 - 60 years old\n* A PFO and a Cryptogenic Stroke verified by a neurologist\n* Stroke is defined as an acute focal neurological deficit, presumed to be due to focal ischemia, and either:\n\n  * Symptoms persisting ≥24 hours, or\n  * Symptoms persisting \\<24 hours with Magnetic Resonance or CT findings of a new, neuroanatomical relevant infarct\n* Cryptogenic stroke was defined as a stroke of unknown cause\n* Prolonged cardiac rhythm monitoring (recommended 30 days and not less than 24 hours required)\n* Intra and extracranial artery imaging: Magnetic Resonance Angiography, CT angiography, or contrast angiography, or contrast angiography or echocardiography of the carotid arteries to rule out ischemic stroke associated with atherosclerotic plaque, arterial dissection, or other vascular diseases. (The aortic arch may also be evaluated by TEE).\n* Hypercoagulable state assessment to rule out an underlying hypercoagulable state\n\nExclusion Criteria:\n\n* Female participant who is pregnant, lactating or planning a pregnancy during the course of the study\n* Age \\<18 or \\> 60 years of age\n* Previous myocardial infarction or unstable angina within 6 months\n* Clinically significant mitral or aortic valve stenosis or severe regurgitation\n* Left Ventricular Ejection Fraction \\<50 percent\n* Progressive neurological dysfunction or reduced life expectancy\n* Contrast allergy\n* Atrial Septal Defect (baseline left to right shunt assessed by TEE or other congenital heart diseases\n* Active Endocarditis\n* Perspective participants with known causes of Ischemic Stroke\n* Arterial dissection\n* Contraindicated or unsuitable for antiplatelet agents or oral anticoagulants\n* Perspective participants with prosthetic heart valves\n* Uncontrolled diabetes Mellitus\n* Pulmonary hypertension\n* Uncontrolled systemic hypertension\n* Intracranial pathology\n* Neurological deficits not due to stroke that may affect neurologic assessments\n* Active autoimmune disease\n* Active infection\n* Alcohol and/or drug abuse\n* A requirement for chronic anticoagulation therapy that cannot be discontinued\n* Anatomic features (inability to achieve vascular access)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"60 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Anthony A Nobles, PhD","affiliation":"Nobles Medical Technologies II Inc","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"TMC HealthCare","city":"Tucson","state":"Arizona","zip":"85712","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"USF/Tampa General Hospital","city":"Tampa","state":"Florida","zip":"33606","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Lehigh Valley Health Network","city":"Allentown","state":"Pennsylvania","zip":"18103","country":"United States","geoPoint":{"lat":40.60843,"lon":-75.49018}},{"facility":"Inova Structural Heart Disease Program - Fairfax","city":"Fairfax","state":"Virginia","zip":"22042","country":"United States","geoPoint":{"lat":38.84622,"lon":-77.30637}},{"facility":"Ospedale S. Eugenio","city":"Roma","state":"Lazio","zip":"00144","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}}]},"referencesModule":{"references":[{"pmid":"29616629","type":"BACKGROUND","citation":"Gaspardone A, De Marco F, Sgueglia GA, De Santis A, Iamele M, D'Ascoli E, Tusa M, Corciu A, Mullen M, Nobles A, Carminati M, Bedogni F. Novel percutaneous suture-mediated patent foramen ovale closure technique: early results of the NobleStitch EL Italian Registry. EuroIntervention. 2018 Jun 8;14(3):e272-e279. doi: 10.4244/EIJ-D-18-00023."}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"Individual participant data (IPD) from the completed STITCH clinical trial that underlie the results reported in the Study, shall after deidentification (text, tables, figures, and appendices).","infoTypes":["STUDY_PROTOCOL"],"timeFrame":"Immediately the following publication and ending 24 months after publication","accessCriteria":"Will be available to Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose. It will be available for Individual participant data meta-analysis"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000054092","term":"Foramen Ovale, Patent"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000006344","term":"Heart Septal Defects, Atrial"},{"id":"D000006343","term":"Heart Septal Defects"},{"id":"D000006330","term":"Heart Defects, Congenital"},{"id":"D000018376","term":"Cardiovascular Abnormalities"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000000013","term":"Congenital Abnormalities"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M14540","name":"Recurrence","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke, Ischemic","relevance":"HIGH"},{"id":"M27260","name":"Foramen Ovale, Patent","asFound":"Foramen Ovale, Patent","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M9122","name":"Heart Septal Defects, Atrial","relevance":"LOW"},{"id":"M9121","name":"Heart Septal Defects","relevance":"LOW"},{"id":"M9108","name":"Heart Defects, Congenital","relevance":"LOW"},{"id":"M12","name":"Congenital Abnormalities","relevance":"LOW"},{"id":"M20193","name":"Cardiovascular Abnormalities","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"}]}},"hasResults":false}